171 related articles for article (PubMed ID: 26706516)
1. Tamoxifen-loaded poly(L-lactide) nanoparticles: Development, characterization and in vitro evaluation of cytotoxicity.
Altmeyer C; Karam TK; Khalil NM; Mainardes RM
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():135-142. PubMed ID: 26706516
[TBL] [Abstract][Full Text] [Related]
2. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
3. Poly(L-lactide) Nanoparticles Reduce Amphotericin B Cytotoxicity and Maintain Its In Vitro Antifungal Activity.
Casa DM; Carraro TC; de Camargo LE; Dalmolin LF; Khalil NM; Mainardes RM
J Nanosci Nanotechnol; 2015 Jan; 15(1):848-54. PubMed ID: 26328449
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems.
Pérez E; Benito M; Teijón C; Olmo R; Teijón JM; Blanco MD
J Microencapsul; 2012; 29(4):309-22. PubMed ID: 22251238
[TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
[TBL] [Abstract][Full Text] [Related]
6. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Jain AK; Thanki K; Jain S
Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
[TBL] [Abstract][Full Text] [Related]
7. Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.
Martínez A; Olmo R; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 Jan; 31(1):182-93. PubMed ID: 23921489
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of host-guest system to enhance the tamoxifen efficiency.
Heidari Majd M; Akbarzadeh A; Sargazi A
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):441-447. PubMed ID: 27012732
[TBL] [Abstract][Full Text] [Related]
10. Delivery of vanillin by poly(lactic-acid) nanoparticles: Development, characterization and in vitro evaluation of antioxidant activity.
Dalmolin LF; Khalil NM; Mainardes RM
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():1-8. PubMed ID: 26952391
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
Pandey SK; Patel DK; Maurya AK; Thakur R; Mishra DP; Vinayak M; Haldar C; Maiti P
Int J Biol Macromol; 2016 Aug; 89():99-110. PubMed ID: 27112980
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen citrate-loaded poly(d,l) lactic acid nanoparticles: Evaluation for their anticancer activity in vitro and in vivo.
Ravikumara NR; Bharadwaj M; Madhusudhan B
J Biomater Appl; 2016 Nov; 31(5):755-772. PubMed ID: 27664187
[TBL] [Abstract][Full Text] [Related]
13. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
Hu FX; Neoh KG; Kang ET
Biomaterials; 2006 Nov; 27(33):5725-33. PubMed ID: 16890989
[TBL] [Abstract][Full Text] [Related]
15. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
Patel PJ; Gohel MC; Acharya SR
Pharm Dev Technol; 2014 Mar; 19(2):200-12. PubMed ID: 23432525
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy.
Alemrayat B; Elhissi A; Younes HM
Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of tamoxifen citrate encapsulated in cross-linked guar gum nanoparticles.
Sarmah JK; Mahanta R; Bhattacharjee SK; Mahanta R; Biswas A
Int J Biol Macromol; 2011 Oct; 49(3):390-6. PubMed ID: 21641924
[TBL] [Abstract][Full Text] [Related]
18. Factorial design optimization and characterization of poly-lactic acid (PLA) nanoparticle formation for the delivery of grape extracts.
Fernández K; Aburto J; von Plessing C; Rockel M; Aspé E
Food Chem; 2016 Sep; 207():75-85. PubMed ID: 27080882
[TBL] [Abstract][Full Text] [Related]
19. Development of biodegradable nanoparticles for delivery of quercetin.
Kumari A; Yadav SK; Pakade YB; Singh B; Yadav SC
Colloids Surf B Biointerfaces; 2010 Oct; 80(2):184-92. PubMed ID: 20598513
[TBL] [Abstract][Full Text] [Related]
20. Poly(lactic acid) nanoparticles loaded with ursolic acid: Characterization and in vitro evaluation of radical scavenging activity and cytotoxicity.
Antônio E; Antunes ODR; de Araújo IS; Khalil NM; Mainardes RM
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():156-166. PubMed ID: 27987693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
